12
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Tea consumption and long-term risk of type 2 diabetes and diabetic complications: a cohort study of 0.5 million Chinese adults

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          ABSTRACT

          Background

          Evidence from epidemiological studies remains inconsistent or limited about the associations of tea consumption with incident diabetes and risk of diabetic complications and death among patients with diabetes.

          Objectives

          We aimed to investigate the associations of tea consumption with long-term risk of developing type 2 diabetes (T2D) and risks of diabetic complications and death among patients with diabetes.

          Methods

          This study included 482,425 diabetes-free participants and 30,300 patients with diabetes aged 30–79 y at study enrollment from the China Kadoorie Biobank. Tea consumption information was collected at baseline by interviewer-administered questionnaires. Incidences of diabetes, diabetic complications, and death were identified by linkages to the National Health Insurance system, disease registries, and death registries. Cox proportional hazard regression models were used to estimate HRs and 95% CIs.

          Results

          The mean ± SD age of participants free of diabetes was 51.2 ± 10.5 y and 41% were male. The mean ± SD age of patients with diabetes was 58.2 ± 9.6 y and 39% were male. Of all daily tea consumers, 85.8% preferred green tea. In the diabetes-free population, 17,434 participants developed incident T2D during 11.1 y of follow-up. Compared with participants who never consumed tea in the past year, the HR (95% CI) of T2D for daily consumers was 0.92 (0.88, 0.97). In patients with diabetes, we identified 6572 deaths, 12,677 diabetic macrovascular cases, and 2441 diabetic microvascular cases during follow-up. Compared with patients who never consumed tea in the past year, the HRs (95% CIs) of all-cause mortality and risk of microvascular complications for daily consumers were 0.90 (0.83, 0.97) and 0.88 (0.78, 1.00), respectively. Tea consumption was not associated with risk of macrovascular complications among patients with diabetes. With regard to tea consumed, the inverse associations between daily tea consumption and risks of T2D and all-cause mortality in patients with diabetes were only observed among daily green tea drinkers.

          Conclusions

          In Chinese adults, daily green tea consumption was associated with a lower risk of incident T2D and a lower risk of all-cause mortality in patients with diabetes, but the associations for other types of tea were less clear. In addition, daily tea consumption was associated with a lower risk of diabetic microvascular complications, but not macrovascular complications.

          Related collections

          Most cited references35

          • Record: found
          • Abstract: found
          • Article: not found

          WITHDRAWN: Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition

          To provide global estimates of diabetes prevalence for 2019 and projections for 2030 and 2045.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study

            Abstract Objective To assess the prevalence of diabetes and its risk factors. Design Population based, cross sectional study. Setting 31 provinces in mainland China with nationally representative cross sectional data from 2015 to 2017. Participants 75 880 participants aged 18 and older—a nationally representative sample of the mainland Chinese population. Main outcome measures Prevalence of diabetes among adults living in China, and the prevalence by sex, regions, and ethnic groups, estimated by the 2018 American Diabetes Association (ADA) and the World Health Organization diagnostic criteria. Demographic characteristics, lifestyle, and history of disease were recorded by participants on a questionnaire. Anthropometric and clinical assessments were made of serum concentrations of fasting plasma glucose (one measurement), two hour plasma glucose, and glycated haemoglobin (HbA1c). Results The weighted prevalence of total diabetes (n=9772), self-reported diabetes (n=4464), newly diagnosed diabetes (n=5308), and prediabetes (n=27 230) diagnosed by the ADA criteria were 12.8% (95% confidence interval 12.0% to 13.6%), 6.0% (5.4% to 6.7%), 6.8% (6.1% to 7.4%), and 35.2% (33.5% to 37.0%), respectively, among adults living in China. The weighted prevalence of total diabetes was higher among adults aged 50 and older and among men. The prevalence of total diabetes in 31 provinces ranged from 6.2% in Guizhou to 19.9% in Inner Mongolia. Han ethnicity had the highest prevalence of diabetes (12.8%) and Hui ethnicity had the lowest (6.3%) among five investigated ethnicities. The weighted prevalence of total diabetes (n=8385) using the WHO criteria was 11.2% (95% confidence interval 10.5% to 11.9%). Conclusion The prevalence of diabetes has increased slightly from 2007 to 2017 among adults living in China. The findings indicate that diabetes is an important public health problem in China.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Diabetes mellitus, fasting glucose, and risk of cause-specific death.

              The extent to which diabetes mellitus or hyperglycemia is related to risk of death from cancer or other nonvascular conditions is uncertain. We calculated hazard ratios for cause-specific death, according to baseline diabetes status or fasting glucose level, from individual-participant data on 123,205 deaths among 820,900 people in 97 prospective studies. After adjustment for age, sex, smoking status, and body-mass index, hazard ratios among persons with diabetes as compared with persons without diabetes were as follows: 1.80 (95% confidence interval [CI], 1.71 to 1.90) for death from any cause, 1.25 (95% CI, 1.19 to 1.31) for death from cancer, 2.32 (95% CI, 2.11 to 2.56) for death from vascular causes, and 1.73 (95% CI, 1.62 to 1.85) for death from other causes. Diabetes (vs. no diabetes) was moderately associated with death from cancers of the liver, pancreas, ovary, colorectum, lung, bladder, and breast. Aside from cancer and vascular disease, diabetes (vs. no diabetes) was also associated with death from renal disease, liver disease, pneumonia and other infectious diseases, mental disorders, nonhepatic digestive diseases, external causes, intentional self-harm, nervous-system disorders, and chronic obstructive pulmonary disease. Hazard ratios were appreciably reduced after further adjustment for glycemia measures, but not after adjustment for systolic blood pressure, lipid levels, inflammation or renal markers. Fasting glucose levels exceeding 100 mg per deciliter (5.6 mmol per liter), but not levels of 70 to 100 mg per deciliter (3.9 to 5.6 mmol per liter), were associated with death. A 50-year-old with diabetes died, on average, 6 years earlier than a counterpart without diabetes, with about 40% of the difference in survival attributable to excess nonvascular deaths. In addition to vascular disease, diabetes is associated with substantial premature death from several cancers, infectious diseases, external causes, intentional self-harm, and degenerative disorders, independent of several major risk factors. (Funded by the British Heart Foundation and others.).
                Bookmark

                Author and article information

                Contributors
                Journal
                Am J Clin Nutr
                Am J Clin Nutr
                ajcn
                The American Journal of Clinical Nutrition
                Oxford University Press
                0002-9165
                1938-3207
                July 2021
                11 March 2021
                11 March 2021
                : 114
                : 1
                : 194-202
                Affiliations
                Department of Epidemiology and Biostatistics, School of Public Health, Peking University , Beijing, China
                Department of Epidemiology and Biostatistics, School of Public Health, Peking University , Beijing, China
                Peking University Center for Public Health and Epidemic Preparedness and Response , Beijing, China
                Chinese Academy of Medical Sciences , Beijing, China
                Chinese Academy of Medical Sciences , Beijing, China
                Department of Epidemiology and Biostatistics, School of Public Health, Peking University , Beijing, China
                Department of Epidemiology and Biostatistics, School of Public Health, Peking University , Beijing, China
                Peking University Center for Public Health and Epidemic Preparedness and Response , Beijing, China
                Medical Research Council Population Health Research Unit, Nuffield Department of Population Health, University of Oxford , Oxford, United Kingdom
                Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford , Oxford, United Kingdom
                Medical Research Council Population Health Research Unit, Nuffield Department of Population Health, University of Oxford , Oxford, United Kingdom
                Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford , Oxford, United Kingdom
                Medical Research Council Population Health Research Unit, Nuffield Department of Population Health, University of Oxford , Oxford, United Kingdom
                Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford , Oxford, United Kingdom
                NCDs Prevention and Control Department, Heilongjiang CDC , Heilongjiang, China
                China National Center for Food Safety Risk Assessment , Beijing, China
                Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford , Oxford, United Kingdom
                Department of Epidemiology and Biostatistics, School of Public Health, Peking University , Beijing, China
                Peking University Center for Public Health and Epidemic Preparedness and Response , Beijing, China
                Key Laboratory of Molecular Cardiovascular Sciences (Peking University), Ministry of Education , Beijing, China
                Department of Epidemiology and Biostatistics, School of Public Health, Peking University , Beijing, China
                Peking University Center for Public Health and Epidemic Preparedness and Response , Beijing, China
                Author notes
                Address correspondence to JL (e-mail: lvjun@ 123456bjmu.edu.cn )
                Author information
                https://orcid.org/0000-0002-4826-8861
                https://orcid.org/0000-0002-9814-0049
                https://orcid.org/0000-0001-5873-7089
                Article
                nqab006
                10.1093/ajcn/nqab006
                8246622
                33709113
                61204282-9b92-4917-841a-9c01a0a4c862
                © The Author(s) 2021. Published by Oxford University Press on behalf of the American Society for Nutrition.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited

                History
                : 23 October 2020
                : 04 January 2021
                Page count
                Pages: 9
                Funding
                Funded by: National Natural Science Foundation of China, DOI 10.13039/501100001809;
                Award ID: 81941018
                Award ID: 81390540
                Award ID: 81390541
                Award ID: 81390544
                Funded by: Kadoorie Charitable Foundation;
                Award ID: 2016YFC0900500
                Award ID: 2016YFC0900501
                Award ID: 2016YFC0900504
                Funded by: National Key Research and Development Program of China, DOI 10.13039/501100012166;
                Funded by: Chinese Ministry of Science and Technology, DOI 10.13039/501100002855;
                Award ID: 2011BAI09B01
                Categories
                Original Research Communications
                Nutritional Epidemiology and Public Health
                AcademicSubjects/MED00060
                AcademicSubjects/MED00160

                Nutrition & Dietetics
                tea consumption,type 2 diabetes,diabetic complications,death,prospective cohort study,china kadoorie biobank

                Comments

                Comment on this article